<DOC>
	<DOCNO>NCT01181973</DOCNO>
	<brief_summary>The hypothesis test bioavailability new 30-mg vial similar current approve 15 -mg vial . In addition , SC injection use new 30-mg vial safe well-tolerated .</brief_summary>
	<brief_title>Safety , Tolerability Relative Bioavailability Pegvisomant Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male female age 21 55 year Positive urine drug screen Excessive use alcohol nicotinecontaining product Pregnant nursing female</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Relative bioavailability</keyword>
	<keyword>pegvisomant</keyword>
</DOC>